Put an idea through history

Create a Tilt about AI revolutionizing biotech.
AI Biotech: Recursion, Absci and Schrödinger, equally weighted.
Backtest it.
October 8–December 31, 2025 price backtest: AI Biotech −21.02%; SPY +1.31%. Equal initial weights, fixed shares; no rebalancing, fees or dividends.
Show me against a sectorial benchmark instead.
IBB tracks U.S.-listed biotechnology companies. Same price backtest: AI Biotech −21.02%; IBB +11.04%.
Nice.
Glad that helped.